Coelho Rogerio Vivaldi Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Coelho Rogerio Vivaldi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Coelho Rogerio Vivaldi. Coelho Rogerio Vivaldi is Chief Commercial Officer in Spark Therapeutics, Inc. ($ONCE) and EVP, Chief Global Therapeutics in Bioverativ Inc. ($BIVV) and President and CEO in Sigilon Therapeutics, Inc. ($SGTX).
Latest Insider Trading Transactions of Coelho Rogerio Vivaldi
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BIVV, SGTX, ONCE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Vivaldi Coelho Rogerio | President and CEO | Option Exercise | C | 0.00 | 22,222 | 0 | 0 | |
| Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Vivaldi Coelho Rogerio | President and CEO | Buy | C | 0.00 | 22,222 | 0 | 22,222 | 0 to 22.2 K |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | D | 44.51 | 56,615 | 2,519,934 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | D | 44.51 | 113,230 | 5,039,867 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | D | 0.00 | 42,727 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | D | 0.00 | 14,230 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Sell | D | 0.00 | 5,758 | 0 | 0 | 5.8 K to 0 (-100.00 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | M | 0.00 | 7,114 | 0 | 14,230 | |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Payment of Exercise | F | 103.52 | 2,126 | 220,084 | 5,303 | 7.4 K to 5.3 K (-28.62 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Buy | M | 0.00 | 7,114 | 0 | 7,429 | 315 to 7.4 K (+2,258.41 %) |
| Feb 02 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | A | 0.00 | 42,727 | 0 | 42,727 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | A | 44.51 | 113,028 | 5,030,876 | 113,028 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | A | 44.51 | 56,514 | 2,515,438 | 56,514 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | A | 0.00 | 21,344 | 0 | 21,344 | |
| Jul 19 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Option Exercise | M | 7.50 | 5,000 | 37,500 | 155,186 | |
| Jul 19 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Option Exercise | M | 3.45 | 1,000 | 3,450 | 10,203 | |
| Jul 19 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Option Exercise | M | 3.45 | 1,000 | 3,450 | 9,116 | |
| Jul 19 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Sell | S | 53.32 | 1,400 | 74,648 | 18,716 | 20.1 K to 18.7 K (-6.96 %) |
| Jul 19 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Sell | S | 52.96 | 5,600 | 296,576 | 20,116 | 25.7 K to 20.1 K (-21.78 %) |
| Jul 19 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Buy | M | 7.50 | 5,000 | 37,500 | 25,716 | 20.7 K to 25.7 K (+24.14 %) |
| Jul 19 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Buy | M | 3.45 | 1,000 | 3,450 | 20,716 | 19.7 K to 20.7 K (+5.07 %) |
| Jul 19 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Buy | M | 3.45 | 1,000 | 3,450 | 19,716 | 18.7 K to 19.7 K (+5.34 %) |
| Apr 22 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Option Exercise | M | 7.50 | 200 | 1,500 | 160,186 | |
| Apr 22 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Option Exercise | M | 3.45 | 1,000 | 3,450 | 10,116 | |
| Apr 22 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Option Exercise | M | 7.50 | 4,800 | 36,000 | 160,386 | |
| Apr 22 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Option Exercise | M | 3.45 | 1,000 | 3,450 | 11,203 | |
| Apr 22 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Sell | S | 40.02 | 1,200 | 48,024 | 18,716 | 19.9 K to 18.7 K (-6.03 %) |
| Apr 22 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Buy | M | 7.50 | 200 | 1,500 | 19,916 | 19.7 K to 19.9 K (+1.01 %) |
| Apr 22 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Buy | M | 3.45 | 1,000 | 3,450 | 19,716 | 18.7 K to 19.7 K (+5.34 %) |
| Apr 22 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Sell | S | 40.02 | 5,800 | 232,116 | 18,716 | 24.5 K to 18.7 K (-23.66 %) |
| Apr 22 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Buy | M | 7.50 | 4,800 | 36,000 | 24,516 | 19.7 K to 24.5 K (+24.35 %) |
| Apr 22 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Buy | M | 3.45 | 1,000 | 3,450 | 19,716 | 18.7 K to 19.7 K (+5.34 %) |
| Jan 07 2016 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Option Exercise | A | 40.44 | 55,000 | 2,224,200 | 55,000 | |
| Oct 14 2015 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Option Exercise | M | 7.50 | 37,333 | 279,998 | 165,186 | |
| Oct 14 2015 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Sell | S | 48.15 | 24,000 | 1,155,600 | 18,716 | 42.7 K to 18.7 K (-56.19 %) |
| Oct 14 2015 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Buy | M | 7.50 | 37,333 | 279,998 | 42,716 | 5.4 K to 42.7 K (+693.54 %) |
| Oct 09 2015 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Option Exercise | M | 7.50 | 30,000 | 225,000 | 202,519 | |
| Oct 09 2015 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Option Exercise | M | 3.45 | 5,000 | 17,250 | 12,203 | |
| Oct 09 2015 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Option Exercise | M | 3.45 | 5,000 | 17,250 | 11,116 | |
| Oct 09 2015 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Sell | S | 50.40 | 1,000 | 50,400 | 5,383 | 6.4 K to 5.4 K (-15.67 %) |
| Oct 09 2015 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Sell | S | 48.81 | 40,000 | 1,952,400 | 6,383 | 46.4 K to 6.4 K (-86.24 %) |
| Oct 09 2015 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Buy | M | 7.50 | 30,000 | 225,000 | 46,383 | 16.4 K to 46.4 K (+183.12 %) |
| Oct 09 2015 | ONCE | Spark Therapeutics ... | Vivaldi Coelho Rogerio | Chief Commercial Of ... | Buy | M | 3.45 | 10,000 | 34,500 | 16,383 | 6.4 K to 16.4 K (+156.67 %) |
Page: 1